Jason W. Mastaitis
Affiliations: | Internal Medicine/Endocrinology | Yale University, New Haven, CT |
Area:
Diabetes, HypoglycemiaGoogle:
"Jason Mastaitis"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Altarejos JY, Pangilinan J, Podgrabinska S, et al. (2023) Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency. Science Translational Medicine. 15: eadd4897 |
| Adam RC, Pryce DS, Lee JS, et al. (2023) Activin E-ACVR1C cross talk controls energy storage via suppression of adipose lipolysis in mice. Proceedings of the National Academy of Sciences of the United States of America. 120: e2309967120 |
| Mastaitis J, Eckersdorff M, Min S, et al. (2015) Loss of SFRP4 Alters Body Size, Food Intake and Energy Expenditure in Diet-Induced Obese Male Mice. Endocrinology. en20151257 |
| Fan X, Chan O, Ding Y, et al. (2015) Reduction in SGLT1 mRNA Expression in the Ventromedial Hypothalamus Improves the Counterregulatory Responses to Hypoglycemia in Recurrently Hypoglycemic and Diabetic Rats. Diabetes |
| Mastaitis J, Min S, Elvert R, et al. (2015) GPR17 gene disruption does not alter food intake or glucose homeostasis in mice. Proceedings of the National Academy of Sciences of the United States of America. 112: 1845-9 |
| Mobbs CV, Mastaitis J, Isoda F, et al. (2013) Treatment of diabetes and diabetic complications with a ketogenic diet. Journal of Child Neurology. 28: 1009-14 |
| Yang L, Isoda F, Yen K, et al. (2012) Hypothalamic Fkbp51 is induced by fasting, and elevated hypothalamic expression promotes obese phenotypes. American Journal of Physiology. Endocrinology and Metabolism. 302: E987-91 |
| Poplawski MM, Mastaitis JW, Isoda F, et al. (2011) Reversal of diabetic nephropathy by a ketogenic diet. Plos One. 6: e18604 |
| Poplawski MM, Mastaitis JW, Mobbs CV. (2011) Naloxone, but not valsartan, preserves responses to hypoglycemia after antecedent hypoglycemia: role of metabolic reprogramming in counterregulatory failure. Diabetes. 60: 39-46 |
| Poplawski MM, Mastaitis JW, Yang XJ, et al. (2010) Hypothalamic responses to fasting indicate metabolic reprogramming away from glycolysis toward lipid oxidation. Endocrinology. 151: 5206-17 |